<HashMap><database>biostudies-literature</database><scores><citationCount>0</citationCount><reanalysisCount>0</reanalysisCount><viewCount>71</viewCount><searchCount>0</searchCount></scores><additional><omics_type>Unknown</omics_type><volume>8(21)</volume><submitter>Zu C</submitter><pubmed_abstract>The functional roles and clinical significances of miR-590-3p in ICC remain unclear. In the current study, we investigated the expression of miR-590-3p in tissues and sera of ICC by real-time quantitative polymerase chain reaction. We found miR-590-3p was significantly down-regulated in the sera and tissues of ICC patients, especially in those patients with lymph node metastasis or distant metastasis. AUC curves and Cox proportional hazards mode revealed serum miR-590-3p could be novel diagnostic and prognostic biomarker for ICC patients. MiR-590-3p dramatically suppressed epithelial-mesenchymal transition, cell migration, and invasion of ICC cells. SIP1 was identified as direct and functional target of miR-590-3p in ICC cells by luciferase assays. Finally, we found SIP1 expression was inversely correlated with miR-590-3p and closely related to diminished survival in ICC patients. These findings reveal functional and mechanistic roles of miR-590-3p and EMT activator SIP1 in the pathogenesis of ICC.</pubmed_abstract><journal>Oncotarget</journal><pagination>34698-34708</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC5471004</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>MiR-590-3p suppresses epithelial-mesenchymal transition in intrahepatic cholangiocarcinoma by inhibiting SIP1 expression.</pubmed_title><pmcid>PMC5471004</pmcid><pubmed_authors>Cheng C</pubmed_authors><pubmed_authors>Liu Z</pubmed_authors><pubmed_authors>Li Y</pubmed_authors><pubmed_authors>Li J</pubmed_authors><pubmed_authors>Zu C</pubmed_authors><pubmed_authors>Cao W</pubmed_authors><pubmed_authors>Ji L</pubmed_authors><pubmed_authors>Qiang H</pubmed_authors><pubmed_authors>Liu S</pubmed_authors><view_count>71</view_count></additional><is_claimable>false</is_claimable><name>MiR-590-3p suppresses epithelial-mesenchymal transition in intrahepatic cholangiocarcinoma by inhibiting SIP1 expression.</name><description>The functional roles and clinical significances of miR-590-3p in ICC remain unclear. In the current study, we investigated the expression of miR-590-3p in tissues and sera of ICC by real-time quantitative polymerase chain reaction. We found miR-590-3p was significantly down-regulated in the sera and tissues of ICC patients, especially in those patients with lymph node metastasis or distant metastasis. AUC curves and Cox proportional hazards mode revealed serum miR-590-3p could be novel diagnostic and prognostic biomarker for ICC patients. MiR-590-3p dramatically suppressed epithelial-mesenchymal transition, cell migration, and invasion of ICC cells. SIP1 was identified as direct and functional target of miR-590-3p in ICC cells by luciferase assays. Finally, we found SIP1 expression was inversely correlated with miR-590-3p and closely related to diminished survival in ICC patients. These findings reveal functional and mechanistic roles of miR-590-3p and EMT activator SIP1 in the pathogenesis of ICC.</description><dates><release>2017-01-01T00:00:00Z</release><publication>2017 May</publication><modification>2024-12-03T16:48:08.482Z</modification><creation>2019-03-27T02:47:38Z</creation></dates><accession>S-EPMC5471004</accession><cross_references><pubmed>28423728</pubmed><doi>10.18632/oncotarget.16150</doi></cross_references></HashMap>